Form 4: Teleflex Director Jaewon Ryu Receives Equity Grant

Director Jaewon Ryu was granted 1,090 restricted stock units and 2,397 stock options as part of the Teleflex 2023 Stock Incentive Plan.

Summary

• Director Jaewon Ryu acquired 1,090 restricted stock units (RSUs) on May 15, 2026.
• Director Jaewon Ryu was granted 2,397 stock options with an exercise price of $129.71.
• The awards vest on the one-year anniversary of the grant date, subject to specific conditions regarding board re-election.
• Following these transactions, the reporting person's direct beneficial ownership of common stock increased to 4,817 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no material impact on company operations.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.
• Standard retention mechanism for board members via the 2023 Stock Incentive Plan.

Negatives

• Minor dilution of existing shareholders due to the issuance of new equity and options.

Risks

• Potential for future share price volatility impacting the value of the granted options.
• Vesting conditions tied to board service and re-election schedules.

Future Outlook

The awards are subject to vesting conditions linked to the 2027 Annual Meeting of stockholders, ensuring continued board service.

Management Comments

• The awards were granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the medical device industry to ensure board alignment with long-term strategic goals.

Comparison to Industry Standards

• Equity-based compensation for directors is consistent with peer medical technology companies such as Medtronic or Edwards Lifesciences.
• Vesting schedules of one year are standard for director compensation packages.

Stakeholder Impact

• Shareholders experience minor dilution from the issuance of new equity.

Next Steps

• Vesting of RSU and stock option awards on May 15, 2027.

Key Dates

Keywords

Teleflex, TFX, Form 4, Director Compensation, Equity Grant, Insider Trading